On March 31, 2016, Arnold Tinter resigned from all executive officer positions with Peak Pharmaceuticals, Inc., including Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer. On April 6, 2016, the company appointed Neil Reithinger as Chief Executive Officer and Chief Financial Officer of the company. Simultaneously with his appointment as an officer of the company, Mr. Reithinger was also appointed as a member of the company's Board of Directors.

He was appointed as a board member by the remaining members of the Board to fill the vacancy created by the resignation of Vered Caplan, to serve for her remaining unexpired term, and thereafter, until her successor has been duly elected and qualified. Since 2009, Mr. Reithinger is the Founder and President of Eventus Advisory Group, LLC. He has also been Chief Financial Officer, Secretary and Treasurer of Orgenesis Inc. since August 2014.